Asthma is a disease of the lungs that affects people of all ages and both sexes. About 1 in 13 people in the United States ...

recommendations on assessing asthma symptoms to determine drug treatment and, consequently, undertreat the disease. Asthma patients experience exacerbations often in part because the EPR3 provides ...

Novo Nordisk expects Ozempic, which has been on the market since 2017, will be on Medicare's list of drugs to negotiate prices concessions, Bloomberg reported. The company told USA TODAY that it would ...

Yes, people have died from asthma, including children and adults. Learn about socioeconomic variables and comorbid factors in ...

Your healthcare provider might prescribe oral steroids on a temporary basis to treat a persistent asthma flare-up. In January 2023, the Food and Drug Administration (FDA) approved Airsupra (albuterol ...

Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...

Airsupra (PT027), a new asthma rescue treatment developed by AstraZeneca (AZ) and development partner Avillion, has been approved by the US Food and Drug Administration (FDA). A first-in-class ...

Although bronchial hyperresponsiveness to cholinergic agents is a main feature of asthma, the role of anticholinergic drugs in chronic asthma management has been largely underestimated.

More than 4.5 million people in the Netherlands continue to suffer from drug shortages, which reached record levels last year ...

"This study really looked at preventing accidental ingestions, preventing anaphylaxis, and just making life a little easier ...

A new test can differentiate between various types of asthma via a nasal swab. Researchers hope it can eventually help match ...